Novel MITF targets identified using a two‐step DNA microarray strategy

@article{Hoek2008NovelMT,
  title={Novel MITF targets identified using a two‐step DNA microarray strategy},
  author={K. Hoek and Natalie C Schlegel and O. Eichhoff and D. Widmer and Christian Praetorius and Steingrimur O Einarsson and S. Valgeirsd{\'o}ttir and Kristin Bergsteinsdottir and Alexander Schepsky and R. Dummer and E. Steingr{\'i}msson},
  journal={Pigment Cell & Melanoma Research},
  year={2008},
  volume={21}
}
  • K. Hoek, Natalie C Schlegel, +8 authors E. Steingrímsson
  • Published 2008
  • Biology, Medicine
  • Pigment Cell & Melanoma Research
  • Malignant melanoma is a chemotherapy‐resistant cancer with high mortality. Recent advances in our understanding of the disease at the molecular level have indicated that it shares many characteristics with developmental precursors to melanocytes, the mature pigment‐producing cells of the skin and hair follicles. The development of melanocytes absolutely depends on the action of the microphthalmia‐associated transcription factor (MITF). MITF has been shown to regulate a broad variety of genes… CONTINUE READING
    200 Citations
    A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells
    • 68
    • PDF
    The three M’s: melanoma, microphthalmia‐associated transcription factor and microRNA
    • 57
    • Highly Influenced
    • PDF
    MITF in melanoma: mechanisms behind its expression and activity
    • 117
    • PDF
    Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1.
    • 82
    • Highly Influenced
    • PDF
    High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
    • 24
    Molecular Systems Biology CDK 2 i overcomes BRAFi-Hsp 90 i resistance

    References

    SHOWING 1-10 OF 105 REFERENCES
    Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    • 1,295
    • PDF
    Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.
    • 409
    Identification of Aim-1 as the underwhiteMouse Mutant and Its Transcriptional Regulation by MITF*
    • 93
    • PDF
    Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays
    • 80
    • PDF
    Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.
    • 148
    • PDF
    Comprehensive Expression Profiling of Tumor Cell Lines Identifies Molecular Signatures of Melanoma Progression
    • 231
    • PDF
    Gpnmb is a melanoblast‐expressed, MITF‐dependent gene
    • 45